UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 42

Sortiert nach

2,7-Disubstituted-Pyrrolotriazine Kinase Inhibitors with an Unusually High Degree of Reactive Metabolite Formation

Chemical research in toxicology, 2011-11, Vol.24 (11), p.1994-2003

2011

Volltextzugriff (PDF)

Blood–brain barrier properties of human immunodeficiency virus antiretrovirals

Journal of pharmaceutical sciences, 1999-10, Vol.88 (10), p.950-954

Yazdanian, Mehran

1999

Volltextzugriff (PDF)

CEP-32496: a novel orally active BRAF(V600E) inhibitor with selective cellular and in vivo antitumor activity

Molecular cancer therapeutics, 2012-04, Vol.11 (4), p.930-941

2012

Volltextzugriff (PDF)

CEP-32496: A Novel Orally Active BRAFV600E Inhibitor with Selective Cellular and In Vivo Antitumor Activity

Molecular cancer therapeutics, 2012-04, Vol.11 (4), p.930-941

2012

Volltextzugriff (PDF)

Characterization of the Calu-3 cell line as a tool to screen pulmonary drug delivery

International journal of pharmaceutics, 2000-11, Vol.208 (1), p.1-11

2000

Volltextzugriff (PDF)

Commentary: Why Pharmaceutical Scientists in Early Drug Discovery Are Critical for Influencing the Design and Selection of Optimal Drug Candidates

AAPS PharmSciTech, 2018, Vol.19 (1), p.1-10

2018

Volltextzugriff (PDF)

A Comprehensive Study Demonstrating that P-glycoprotein Function is Directly Affected by Changes in pH: Implications for Intestinal pH and Effects on Drug Absorption

Journal of pharmaceutical sciences, 2011-10, Vol.100 (10), p.4258-4268

2011

Volltextzugriff (PDF)

Correlating partitioning and caco-2 cell permeability of structurally diverse small molecular weight compounds

Pharmaceutical research, 1998-09, Vol.15 (9), p.1490-1494

1998

Volltextzugriff (PDF)

Discovery and Characterization of 6-{4-[3-( R )-2-Methylpyrrolidin-1-yl)propoxy]phenyl}-2 H -pyridazin-3-one (CEP-26401, Irdabisant): A Potent, Selective Histamine H 3 Receptor Inverse Agonist

Journal of medicinal chemistry, 2011-07, Vol.54 (13), p.4781-4792

2011

Volltextzugriff (PDF)

Discovery and Characterization of 6-{4-[3-(R)-2-Methylpyrrolidin-1-yl)propoxy]phenyl}-2H-pyridazin-3-one (CEP-26401, Irdabisant): A Potent, Selective Histamine H3 Receptor Inverse Agonist

Journal of medicinal chemistry, 2011-07, Vol.54 (13), p.4781-4792

2011

Volltextzugriff (PDF)

Divalent cation-stearic acid monolayer interactions at the air/water interface

Langmuir, 1992-02, Vol.8 (2), p.630-636

1992

Volltextzugriff (PDF)

Early development GMPs for small-molecule specifications: an industry perspective (part v)

Pharmaceutical technology Europe, 2012-11, Vol.24 (11), p.26

2012

Volltextzugriff (PDF)

Early development GMPs for small-molecule specifications: an industry perspective (Part V)

Pharmaceutical Technology, 2012-10, Vol.36 (10), p.86

2012

Volltextzugriff (PDF)

The Effect of Excipients on the Permeability of BCS Class III Compounds and Implications for Biowaivers

Pharmaceutical research, 2016-01, Vol.33 (1), p.167-176

2016

Volltextzugriff (PDF)

The effect of freezing on cattle skin permeability

International journal of pharmaceutics, 1994-02, Vol.103 (1), p.93-96

Yazdanian, Mehran

1994

Volltextzugriff (PDF)

An ellipsometric study of polymer monolayers at the air/water interface

Macromolecules, 1989-09, Vol.22 (5), p.2332-2337

1989

Volltextzugriff (PDF)

Evaluation of an accelerated Caco‐2 cell permeability model

Journal of pharmaceutical sciences, 2000-03, Vol.89 (3), p.336-345

2000

Volltextzugriff (PDF)

Evaluation of an accelerated Caco-2 cell permeability model

Journal of pharmaceutical sciences, 2000-03, Vol.89 (3), p.336

2000

Volltextzugriff (PDF)

Evolution of Choice of Solubility and Dissolution Media After Two Decades of Biopharmaceutical Classification System

The AAPS journal, 2017-07, Vol.19 (4), p.989-1001

2017

Volltextzugriff (PDF)

George Zografi: researcher and educator

Pharmaceutical research, 2006-10, Vol.23 (10), p.2235-2238

2006

Volltextzugriff (PDF)

The "high solubility" definition of the current FDA Guidance on Biopharmaceutical Classification System may be too strict for acidic drugs

Pharmaceutical research, 2004-02, Vol.21 (2), p.293-299

2004

Volltextzugriff (PDF)

Improving the determination of celecoxib in body fluids and pharmaceuticals using a new selective and thermosensitive molecularly imprinted poly(vinylidene fluoride) membrane

Analytical methods, 2020-05, Vol.12 (16), p.2185-2195

2020

Volltextzugriff (PDF)

Influence of Cationic Interactions on Fatty Acid Monolayers Studied by Ellipsometry

MRS proceedings, 1989, Vol.177, Article 405

1989

Volltextzugriff (PDF)

Ionic interactions of fatty acid monolayers at the air/water interface

Yazdanian, Mehran

1990

Volltextzugriff (PDF)

Ionic interactions of fatty acid monolayers at the air/water interface

Langmuir, 1990-06, Vol.6 (6), p.1093-1098

1990

Volltextzugriff (PDF)

1 – 25 von 42

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(37)
Mit Volltextzugriff
(39)

Publikationsform

Sprache

Englisch
(42)
Japanisch
(7)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

2,7-Disubstituted-Pyrrolotriazine Kinase Inhibitors with an Unusually High Degree of Reactive Metabolite Formation

Blood–brain barrier properties of human immunodeficiency virus antiretrovirals

CEP-32496: a novel orally active BRAF(V600E) inhibitor with selective cellular and in vivo antitumor activity

CEP-32496: A Novel Orally Active BRAFV600E Inhibitor with Selective Cellular and In Vivo Antitumor Activity

Characterization of the Calu-3 cell line as a tool to screen pulmonary drug delivery

Commentary: Why Pharmaceutical Scientists in Early Drug Discovery Are Critical for Influencing the Design and Selection of Optimal Drug Candidates

A Comprehensive Study Demonstrating that P-glycoprotein Function is Directly Affected by Changes in pH: Implications for Intestinal pH and Effects on Drug Absorption

Correlating partitioning and caco-2 cell permeability of structurally diverse small molecular weight compounds

Discovery and Characterization of 6-{4-[3-( R )-2-Methylpyrrolidin-1-yl)propoxy]phenyl}-2 H -pyridazin-3-one (CEP-26401, Irdabisant): A Potent, Selective Histamine H 3 Receptor Inverse Agonist

Discovery and Characterization of 6-{4-[3-(R)-2-Methylpyrrolidin-1-yl)propoxy]phenyl}-2H-pyridazin-3-one (CEP-26401, Irdabisant): A Potent, Selective Histamine H3 Receptor Inverse Agonist

Divalent cation-stearic acid monolayer interactions at the air/water interface

Early development GMPs for small-molecule specifications: an industry perspective (part v)

Early development GMPs for small-molecule specifications: an industry perspective (Part V)

The Effect of Excipients on the Permeability of BCS Class III Compounds and Implications for Biowaivers

The effect of freezing on cattle skin permeability

An ellipsometric study of polymer monolayers at the air/water interface

Evaluation of an accelerated Caco‐2 cell permeability model

Evaluation of an accelerated Caco-2 cell permeability model

Evolution of Choice of Solubility and Dissolution Media After Two Decades of Biopharmaceutical Classification System

George Zografi: researcher and educator

The "high solubility" definition of the current FDA Guidance on Biopharmaceutical Classification System may be too strict for acidic drugs

Improving the determination of celecoxib in body fluids and pharmaceuticals using a new selective and thermosensitive molecularly imprinted poly(vinylidene fluoride) membrane

Influence of Cationic Interactions on Fatty Acid Monolayers Studied by Ellipsometry

Ionic interactions of fatty acid monolayers at the air/water interface

Ionic interactions of fatty acid monolayers at the air/water interface

Suchergebnisse filtern